Chemotherapy doublet
WebIntroduction: Although the standard treatment for advanced non-small cell lung cancer (NSCLC) patients is platinum-based doublet chemotherapy, single-agent therapy is still … WebApr 5, 2024 · Adjuvant or neoadjuvant platinum-based doublet chemotherapy (after surgery and/or radiation therapy) if recurrent or metastatic disease develops more than 6 months after completing therapy as long as toxicities have resolved to CTCAE grade ≤1 or baseline with the exception of alopecia and peripheral neuropathy.
Chemotherapy doublet
Did you know?
WebFeb 11, 2011 · It is the combination of platinum-based (cisplatin, carboplatin) chemotherapy AND docetaxel, paclitaxel, vinorelbine, gemcitabine or irinotecan ... based chemotherapy. ...platinum-doublet ... WebMar 26, 2024 · Patients enrolled had EGFR-positive NSCLC who had previously received osimertinib in the first-second, or third-line setting, and then went on to subsequently receive platinum doublet chemotherapy ...
WebPlatinum doublet therapy has been investigated in 7 clinical trials, of which 6 are open and 1 is closed. Of the trials investigating platinum doublet therapy, 4 are phase 2 (3 open), … WebMar 4, 2024 · The recommended nivolumab dose is 360 mg with platinum-doublet chemotherapy on the same day every 3 weeks for 3 cycles. View full prescribing …
WebThe most common adverse reactions in ≥20% of patients receiving nivolumab in combination with ipilimumab and platinum-doublet chemotherapy were fatigue, … WebApr 10, 2013 · Patient has stage IIIB or IV diagnosis and must have received one or two prior regimens (including platinum- doublet) of cytotoxic chemotherapy for the treatment of locally advanced or metastatic NSCLC. Patient has at least one measurable lesion as defined by RECIST 1.1. A previously irradiated site lesion may only be counted as a …
WebPurpose: To assess the efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell lung cancer (NSCLC) through a trial-level meta-analysis. Methods: Trials published between 1990 and 2015 were identified by an electronic search of public databases (Medline, Embase, and Cochrane Library).
WebJun 7, 2024 · The addition of neoadjuvant nivolumab plus platinum-doublet chemotherapy significantly improved pathological complete response (pCR) rates and showed a greater depth of pathological response compared with chemotherapy alone in patients with resectable non–small cell lung cancer (NSCLC), according to results from the phase 3 … blue converse with black heartWebAug 5, 2024 · PARIS and TARRYTOWN, NY – August 5, 2024 - The Phase 3 trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early after meeting its overall survival (OS) primary endpoint in patients with advanced non-small cell lung cancer (NSCLC). Adding Libtayo to … free iobitWebDec 3, 2024 · Nivolumab + platinum-doublet chemotherapy vs chemotherapy as neoadjuvant treatment for resectable (IB–IIIA) non-small cell lung cancer in the phase 3 CheckMate 816 trial. Editor’s note: For additional experts’ perspectives on articles 1 and 2, read our November 2024 Lung Cancer Journal Scan . free iobit uninstaller lisence techno360WebJan 18, 2024 · The perioperative use of toripalimab in combination with platinum-based doublet chemotherapy achieved event-free survival (EFS) improvement in Chinese … blue cookies leaflyWebOct 13, 2024 · The counterpart of the platinum doublet had to be one of the following third-generation chemotherapy agents: Docetaxel (DTX), Paclitaxel (PTX), Vinorelbine … free inzulated lunch box patterns to sewfree io games with usWebFirst-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial Javascript is currently disabled in your browser. … blue contacts green eyes